KIR2DS3 Inhibitors
Chemical inhibitors of KIR2DS3 can exert their inhibitory effects through various mechanisms that affect the signaling pathways and cellular functions integral to the protein's activity. Cyclosporin A and FK506 (Tacrolimus) inhibit the activity of calcineurin, a phosphatase critical for T-cell activation. Since KIR2DS3 is an activating receptor on natural killer (NK) cells, which are modulated by the immune system's broader responses, the dampening of T-cell activation can indirectly reduce the functional milieu required for KIR2DS3's action. Rapamycin (Sirolimus) disrupts cellular proliferation and survival by inhibiting the kinase mTOR, which is essential for NK cell functions, thus indirectly affecting KIR2DS3. The chemical PP2 targets Src family kinases, which participate in initiating the signaling cascades upon which KIR2DS3 activation relies. Similarly, Dasatinib acts as a tyrosine kinase inhibitor, disrupting the Src kinase-mediated signaling pathways essential for KIR2DS3's functional engagement.
Further, PD 98059 and U0126 inhibit the MEK enzymes within the MAPK/ERK pathway, which is connected to the regulatory mechanisms of immune cell activities that include the functioning of KIR2DS3. LY294002 and Wortmannin are PI3K inhibitors that subdue the PI3K/Akt pathway, pivotal in regulating NK cell activation and potentially impacting KIR2DS3's signaling context. The JNK inhibitor SP600125 and the p38 MAPK inhibitor SB203580 disrupt the MAPK pathway, which is involved in immune cell response regulation and cytokine production, processes that can influence KIR2DS3's function. Lastly, BIBF 1120 (Nintedanib) is a broad-spectrum tyrosine kinase inhibitor that can impact signaling pathways within NK cells, thereby modulating the functional context in which KIR2DS3 operates.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A inhibits calcineurin, which is crucial for the activation of T-cells. As KIR2DS3 is an activating receptor on natural killer (NK) cells, its function is dependent on the overall immune response, including T-cell activation. Inhibition of T-cell activation by Cyclosporin A can decrease the functional context in which KIR2DS3 operates, thus inhibiting its function. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
FK506 binds to FKBP12, forming a complex that inhibits calcineurin, leading to suppressed T-cell activation. Reduced T-cell activation can indirectly inhibit the functional environment necessary for KIR2DS3 activity on NK cells. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin forms a complex with FKBP12 which inhibits mTOR, a key kinase in cell proliferation and survival. As KIR2DS3's activity is linked to NK cell function, inhibition of mTOR can reduce the proliferative capacity of NK cells, thus inhibiting KIR2DS3 function indirectly. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an inhibitor of Src family kinases, which are involved in the signaling pathways of various immune receptors, including NK cell receptors like KIR2DS3. By inhibiting Src kinases, PP2 can disrupt the signaling cascade that KIR2DS3 depends upon for its activation. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a broad-spectrum tyrosine kinase inhibitor that can inhibit Src family kinases. The inhibition of these kinases can disrupt the signaling pathways crucial for the activation of KIR2DS3 on NK cells. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 is a specific inhibitor of MEK, which is a part of the MAPK/ERK pathway. This pathway contributes to the regulation of immune cell activities, and its inhibition can indirectly affect the signaling pathways that involve KIR2DS3. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, and PI3K is a critical signaling molecule in many types of immune cells, including NK cells. Inhibiting PI3K can lead to reduced activation of downstream pathways that may be necessary for KIR2DS3 function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor, which can suppress the PI3K/Akt pathway, impacting NK cell function and indirectly inhibiting the signaling context in which KIR2DS3 operates. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, enzymes in the MAPK/ERK pathway. Disruption of this pathway can affect the activation and function of immune cells, including those with KIR2DS3. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which is part of the MAPK pathway. JNK is involved in the regulation of immune responses, and its inhibition can alter the signaling environment of NK cells expressing KIR2DS3. | ||||||